Decoy Therapeutics Q2 net loss widens 148% to $2.37 million; revenue turns to $227,629 from no revenuePUBT·Aug 12 at 03:17 PMDCOY-0.28%
Decoy Therapeutics expands IP portfolio with 1 granted US patent, 19 applications pendingPUBT·Aug 3 at 08:01 AMDCOY-0.28%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·Jul 27 at 12:06 PMMPLT-1.79%PFSA+29.20%
Decoy Therapeutics D-MAV candidate shows in vitro activity against Ebola Zaire virusPUBT·Jul 27 at 08:03 AMDCOY-0.28%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 16 at 07:05 AMATAI-0.21%DCOY-0.28%
Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors | DCOY Stock NewsStockTitan·Jul 15 at 12:24 AMDCOY-0.28%
U.S. stock market midday update: Decoy Therapeutics down 8.54%, volume increased, sector volatility intensifiedPrice Alert·Jul 10 at 01:52 PMDCOY-0.28%
U.S. stock market midday update: Decoy Therapeutics up 13.04%, influx of funds boosts volatilityPrice Alert·Jul 9 at 01:47 PMDCOY-0.28%
